Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$9.53B |
| 2 |
Gilead Sciences
GILD
|
+$8.17B |
| 3 |
Microsoft
MSFT
|
+$7.02B |
| 4 |
Amgen
AMGN
|
+$6.96B |
| 5 |
Altria Group
MO
|
+$5.42B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.95% |
| 2 | Technology | 12.52% |
| 3 | Communication Services | 11.55% |
| 4 | Industrials | 10.7% |
| 5 | Consumer Staples | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Kinder Morgan
KMI
$70.7B
| $1.26B | 0.53% |
+32,910,873
| New | +$1.28B |
|
52
Lockheed Martin
LMT
$140B
| $1.25B | 0.53% |
+11,503,500
| New | +$1.18B |
|
|
GMCR
53
DELISTED
KEURIG GREEN MTN INC
GMCR
| $1.23B | 0.52% |
+16,377,085
| New | +$1.11B |
|
54
Baidu
BIDU
$35.4B
| $1.21B | 0.52% |
+12,836,744
| New | +$1.18B |
|
55
Coca-Cola
KO
$374B
| $1.2B | 0.51% |
+30,001,000
| New | +$1.24B |
|
56
Exelon
EXC
$46.5B
| $1.17B | 0.5% |
+53,327,481
| New | +$1.29B |
|
57
Netflix
NFLX
$309B
| $1.16B | 0.49% |
+384,394,500
| New | +$1.14B |
|
58
Apple
AAPL
$4.4T
| $1.1B | 0.47% |
+77,964,880
| New | +$1.2B |
|
59
Crown Castle
CCI
$31.5B
| $1.08B | 0.46% |
+14,902,550
| New | +$1.09B |
|
60
Intuit
INTU
$90.9B
| $1.06B | 0.45% |
+17,435,000
| New | +$1.05B |
|
61
Devon Energy
DVN
$49.4B
| $1.06B | 0.45% |
+20,401,221
| New | +$1.14B |
|
|
PCP
62
DELISTED
PRECISION CASTPARTS CORP
PCP
| $1.04B | 0.44% |
+4,608,000
| New | +$934M |
|
63
TechnipFMC
FTI
$29.7B
| $1.04B | 0.44% |
+25,097,554
| New | +$1.02B |
|
64
CVS Health
CVS
$121B
| $1.03B | 0.44% |
+17,973,874
| New | +$1.04B |
|
|
MXIM
65
DELISTED
Maxim Integrated Products
MXIM
| $995M | 0.42% |
+35,827,894
| New | +$1.09B |
|
66
PepsiCo
PEP
$189B
| $969M | 0.41% |
+11,843,328
| New | +$967M |
|
67
JPMorgan Chase
JPM
$972B
| $968M | 0.41% |
+18,335,000
| New | +$932M |
|
68
BioMarin Pharmaceuticals
BMRN
$13.7B
| $947M | 0.4% |
+16,968,746
| New | +$1.06B |
|
69
Illumina
ILMN
$28.9B
| $940M | 0.4% |
+12,910,124
| New | +$826M |
|
|
RDS.A
70
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $924M | 0.39% |
+15,504,204
| New | +$959M |
|
71
Edwards Lifesciences
EW
$53.7B
| $919M | 0.39% |
+82,042,800
| New | +$971M |
|
72
Adobe
ADBE
$102B
| $901M | 0.38% |
+19,772,800
| New | +$876M |
|
73
Mondelez International
MDLZ
$79.1B
| $892M | 0.38% |
+31,265,400
| New | +$951M |
|
|
CMCSK
74
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
| $873M | 0.37% |
+22,000,000
| New | +$873M |
|
75
Stryker
SYK
$133B
| $872M | 0.37% |
+13,478,811
| New | +$895M |
|
Similar funds
Capital Research Global Investors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Capital Research Global Investors, which disclosed 433 positions worth $235B. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Philip Morris: 102,547,012 shares worth $8.88B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, followed by Technology and Communication Services.
- Capital Research Global Investors's largest Q2 2013 buy was Philip Morris: 102,547,012 shares worth $8.88B.
- Capital Research Global Investors's ten largest holdings make up 25% of its $235B portfolio in Q2 2013.
- Capital Research Global Investors disclosed 433 positions in Q2 2013, its first 13F filing on record.
Based on Capital Research Global Investors's 13F filing for Q2 2013, filed 14 Aug 2013.